Drug Development

“

Pioneering Next-Generation Therapeutics with the BioDrone™ Platform

Carus Bio is dedicated to developing innovative therapeutics that overcome the limitations of conventional treatments, leveraging its proprietary BioDrone™ (CDV) platform to deliver new hope to patients.

In Vivo CAR Therapeutics

Carus Bio is developing next-generation In Vivo CAR therapeutics that directly reprogram immune cells within the body, eliminating the need for complex ex vivo processes, through the BioDrone™ (CDV) platform.

01
Improved Accessibility

Designed as an off-the-shelf injectable therapy that eliminates the need for apheresis and lymphodepletion procedures.

02
Enhanced Safety & Control

RNA-based transient expression enables precise control over potential side effects such as cytokine release syndrome (CRS), improving the safety profile compared to conventional gene-modified therapies.

03
Targeting Solid Tumors

By leveraging efficient delivery to macrophages, In Vivo CAR-M approaches enable penetration into tumor microenvironments where conventional CAR-T therapies have shown limitations.

Business Model

To maximize the value of the BioDrone™ platform and accelerate global access to innovative therapeutics, we operate a flexible and collaborative partnership model tailored to our partners’ needs.

01
Licensing

We offer global licensing opportunities for our proprietary BioDrone™ platform and innovative pipeline targeting intractable diseases. Partners can leverage our validated research data to reduce development risks and accelerate market entry.

02
Co-Development & Partnerships

We collaborate with partners to create new value by integrating their therapeutic candidates (mRNA, siRNA, proteins, etc.) with our BioDrone™ platform, enhancing stability and efficacy to improve success rates in drug development.

03
Validation & Optimization

We provide tailored solutions to maximize therapeutic performance within the BioDrone™ system. Through customized CDV design and surface engineering, we enhance targeting efficiency while minimizing side effects.

Partnering Inquiry

The BioDrone™-based In Vivo CAR platform is poised to transform cancer treatment.
We are seeking global partners to join us in advancing next-generation therapeutics.

Email